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DObjective: The aim of the present study was to identify the factors associated with right ventricular (RV) dila-
tation and dysfunction in patients with chronic pulmonary regurgitation (PR) after repair of tetralogy of Fallot.
Methods: From April 2002 to June 2013, 218 patients with repaired tetralogy of Fallot underwent magnetic
resonance imaging; 165 (76%) underwent transannular repair and 36 (17%) underwent nontransannular repair.
Linear regression analyses were used to identify the predictors for RV end-diastolic volume index (EDVI),
end-systolic volume index (ESVI), and ejection fraction.
Results: On univariable analysis, male sex, ventricular septal defect (VSD) closure through the right ventricle,
larger pulmonary artery index, and greater PR fraction were associated with greater RV volume indexes.
Multivariable analyses identified male sex (b ¼ 17.55, P<.001 for RV EDVI; b ¼ 14.08, P ¼ .001 for RV
ESVI), VSD closure through RV (b ¼ 8.49, P ¼ .048 for RV ESVI), longer interval since repair (b ¼ 1.29,
P ¼ .014 for RV EDVI), and greater PR fraction (b ¼ 1.92, P<.001 for RV EDVI; b ¼ 1.38, P<.001 for
RV ESVI) as independent predictors for greater RV volume indexes. On univariable analysis, male sex, VSD
closure through the right ventricle, and greater PR fraction were associated with a lower RV ejection fraction.
Multivariable analysis identified male sex (b ¼ 3.10, P ¼ .018), VSD closure through the right ventricle
(b ¼ 3.05, P ¼ .020), and greater PR fraction (b ¼ 0.27, P<.001) as independent predictors for a lower
RV ejection fraction.
Conclusions: Male sex, VSD closure through the right ventricle, longer interval since repair, and greater PR
fraction were independent predictors of RV dilatation after tetralogy of Fallot repair. Male sex, VSD
closure through the right ventricle, and greater PR fraction were also independent predictors of RV dysfunction.
(J Thorac Cardiovasc Surg 2014;148:2589-96)Repair of tetralogy of Fallot (TOF) is being performed with
very low operative mortality, and the patients with repaired
TOF can be expected to have excellent long-term survival.1,2
However, a substantial number of patients will be exposed to
chronic pulmonary regurgitation (PR) owing to the loss of
pulmonary valve competency at the repair. The resultant
chronic volume overload can lead to right ventricular (RV)
dilatation, biventricular dysfunction, heart failure
symptoms, arrhythmias, and sudden death.3 Pulmonary valvehe Departments of Thoracic and Cardiovascular Surgery,a Pediatric
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The Journal of Thoracic and Carreplacement (PVR) has become a common practice to avoid
the dreadful sequelae of chronic PR, although this procedure
is also not without problems.4-8
The factors associated with RV dilatation and dysfunc-
tion in patients with chronic PR after TOF repair are not
completely understood. Understanding these factors could
help identify those patients who need more careful
follow-up to determine the optimal timing of PVR. Also,
understanding these factors might help clarify the optimal
surgical management of TOF for better long-term out-
comes. Magnetic resonance imaging (MRI) is currently
the reference standard for evaluating RV volumes and
function in patients with chronic PR after TOF repair.9,10
The aim of the present study was to identify the factors
associated with RV dilatation and dysfunction in patients
with chronic PR after repair of TOF by analyzing the
MRI data obtained long term after repair.METHODS
The institutional review board of Sejong General Hospital approved the
present retrospective study and waived the need for individual patient
consent.diovascular Surgery c Volume 148, Number 6 2589
Abbreviations and Acronyms
EDVI ¼ end-diastolic volume index
EF ¼ ejection fraction
MRI ¼ magnetic resonance imaging
PAI ¼ pulmonary artery index
PR ¼ pulmonary regurgitation
PVR ¼ pulmonary valve replacement
RV ¼ right ventricular
RVOTO ¼ RVoutflow tract obstruction
TAP ¼ transannular patch
TOF ¼ tetralogy of Fallot
VSD ¼ ventricular septal defect
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D Study Population and Data Collection
By searching the database of our institution, we identified 218 study pa-
tients with repaired TOF who had undergone MRI for evaluation of PR
from April 2002 to June 2013. Of these, 24 patients had undergone repair
at other hospitals. Approximately 1255 patients had undergone TOF repair
during the same period (from 1982 to 2006) when the study population had
undergone TOF repair. The prescription of MRI was at the discretion of the
cardiologist. Excluded from the present study were patients with other sig-
nificant confounding congenital heart defects (eg, atrioventricular septal
defect, major aortopulmonary collateral arteries), right ventricle to pulmo-
nary artery conduits, significant (at least moderate) regurgitation of other
valves, and poor MRI quality with resultant inaccurate volumetric data.
In patients with serial MRI examinations, we used the most recent MRI
data for the analyses. Data were obtained by a review of the medical re-
cords. Echocardiographic, electrocardiographic, and cardiopulmonary ex-
ercise test data within 1 year of the MRI study were obtained for analysis.
The characteristics of the study patients are listed in Table 1.Cardiac MRI
MRI studies were performed with a 1.5-Tesla Gyroscan Intera CV sys-
tem (Philips Medical Systems, Best, The Netherlands). Biventricular volu-
metric analysis was performed using Extended MR Workspace software
(Philips Medical Systems). The details of the MRI protocol used in our
institution for the assessment of patients with repaired TOF have been
described previously.4 A single observer (Y.M.K.) performed all measure-
ments of the branch pulmonary artery size, and the diameters of the narrow-
est portion of the branch pulmonary arteries were measured. From these
measurements, the pulmonary artery index (PAI) was calculated as follows:
(cross-sectional area of the right pulmonary artery [mm2]þ cross-sectional
area of the left pulmonary artery [mm2])/(body surface area [m2]).
Follow-up
The follow-up data were considered complete if the patient’s status had
been determined after January 2012. The mean duration of follow-up since
repair was 19.5 4.9 years, and 77.1% of the study patients had complete
follow-up data. The follow-up completeness, measured by calculating the
Clark index,11 was 93.6%.
Statistical Analysis
The data were tested for normal distribution using the Kolmogorov-
Smirnow test and histogram. Data are presented as frequencies and percent-
ages, mean standard deviation, or median and range, as appropriate. Com-
parisons between independent groups were performed using the
independent samples t test, Mann-Whitney U test, or chi-square test, as
appropriate. Multiple linear regression analysis (backward method) was2590 The Journal of Thoracic and Cardiovascular Surused to identify the independent predictors for the RVend-diastolic volume
index (EDVI), RVend-systolic volume index, and RVejection fraction (EF).
The potential predictors examined were sex, history of palliation, age at
repair, repair type, route of ventricular septal defect (VSD) closure, interval
since repair, presence of RV outflow tract obstruction (RVOTO), PAI, and
PR fraction. Patients with any missing data for these variables were
excluded, and 160 patients were included in the linear regression analysis.
Univariable predictors with P<.15 were entered as potential independent
predictors on multivariable analysis. The Statistical Package for Social Sci-
ences, version 18.0 (SPSS Inc, Chicago, Ill) was used for statistical analysis.RESULTS
Echocardiographic, Electrocardiographic, and
Exercise Test Data at MRI Examination
Echocardiographic data were available for 193 patients
(88.5%). The grade of tricuspid regurgitation was none in
23 patients, trivial in 74, mild in 95, and not available in
1. RVOTO was defined as a peak pressure gradient 25
mm Hg. Ten patients (5.2%) had RVOTO, and the median
peak pressure gradient was 34 mm Hg (range, 27-120).
Electrocardiographic data were available for 141 patients
(64.7%). The mean QRS duration was 141  27 ms, and
6 patients had QRS duration 180 ms. The cardiopulmo-
nary exercise test data were available for 78 patients
(35.8%), and the mean peak oxygen consumption was
29  7 mL/kg/min (70%  16% of the predicted value).Analyses of MRI Data (Predictors for RV Dilatation
and Dysfunction)
The MRI data for the entire study population are listed in
Table 2. As determined on univariable analysis, male sex,
VSD closure through the right ventricle, larger PAI, and
greater PR fraction were associated with greater RV volume
indexes. The multivariable analyses identified male sex,
VSD closure through the right ventricle, a longer interval
since repair, and greater PR fraction as independent predic-
tors of greater RV volume indexes (Tables 3 and 4). As
determined from the univariable analyses, male sex, VSD
closure through the right ventricle, and greater PR fraction
were associated with a lower RV EF. Multivariable
analysis identified male sex, VSD closure through the
right ventricle, and greater PR fraction as independent
predictors for a lower RV EF (Table 5).Clinical Outcomes
PVR was performed in 108 patients (49.5%). The me-
dian age at PVR was 19.2 years (range, 7.1-44.3), and the
mean interval between TOF repair and PVR was 16.3 
4.9 years. The operative mortality after PVR was 0.9% (1
of 108). The results of a comparison between the patients
who had undergone PVR and those who had not undergone
PVR are presented in Table 6. Four patients developed atrial
tachyarrhythmia during follow-up. No late death occurred
in the entire study population, except for the PVR mortality
case.gery c December 2014
TABLE 2. Magnetic resonance imaging data for the entire study
population (n ¼ 218)
Variable Value
RV EDVI (mL/m2) 147  36
RV ESVI (mL/m2) 71  30
RV EF (%) 53  9
PR fraction (%) 43  10
PR volume (mL/m2) 32  12
LV EDVI (mL/m2) 76  12
LV ESVI (mL/m2) 29  8
LV EF (%) 62  7
RPA diameter (mm/m2) 9.0  2.8
LPA diameter (mm/m2)* 7.6  2.9
PAI (mm2/m2) 173  94
RV, Right ventricular; EDVI, end-diastolic volume index; ESVI, end-systolic volume
index; EF, ejection fraction; PR, pulmonary regurgitation; LV, left ventricular; RPA,
right pulmonary artery; LPA, left pulmonary artery; PAI, pulmonary artery index.
*Data not available for 3 patients, including 2 patients with interrupted LPA.
TABLE 1. Patient characteristics
Variable Value
Male sex 120 (55)
Palliation before repair 24 (11)
Age at repair
Median 1.7 y




No information 17 (8)
Route of VSD closure
RV 98 (45)
RA 73 (33)
No information or other 47 (22)
Age at MRI (y) 18.8  7.0
Interval between repair and MRI (y) 15.8  4.8
Weight at MRI (kg) 52.7  15.1
BSA at MRI (m2) 1.52  0.28




No information 7 (3)
Data presented as n (%) or mean  standard deviation. TAP, Transannular patch;
VSD, ventricular septal defect; RV, right ventricle; RA, right atrium; MRI, magnetic
resonance imaging; BSA, body surface area; NYHA, New York Heart Association.




The well-documented long-term sequelae associated
with chronic PR after TOF repair have emerged as great
challenges for clinicians.3,10 The response of the right
ventricle to chronic PR has varied among patients with
repaired TOF, and the factors associated with RV
dilatation and dysfunction in these patients are not
completely understood. Previous studies have tried to
identify the risk factors for PVR, a surrogate outcome for
RV dilatation and dysfunction.12-14,16 Because PVR is still
an evolving procedure in terms of its indications and
optimal timing, objective measures of the RV volume and
function are necessary to better elucidate the factors
associated with RV dilatation and dysfunction. Our study
identified independent predictors for RV dilatation and
dysfunction in patients with chronic PR after TOF repair
by analyzing the data obtained with MRI, a reference
standard for evaluating the RV volume and function.
In the present study, male sex was identified as an inde-
pendent predictor for RV dilatation and dysfunction. This
finding is in accordance with the finding from the study
by Spiewak and colleagues,15 which found that male sex
was an independent predictor for larger RV EDVI. Kogon
and colleagues16 found that male sex was an independent
risk factor for a shorter interval between pulmonary valve
disruption and PVR. However, it is difficult to ascertain
whether a true sex-specific difference in the RV responseThe Journal of Thoracic and Carto chronic volume overload exists, because previous studies
found significant sex-specific differences in normal RV vol-
umes, as assessed by MRI.17,18 This issue needs to be
clarified in future studies.
We found that VSD closure through the right ventricle
(transventricular approach) was an independent predictor
for RV dilatation and dysfunction. Controversy regarding
the optimal surgical technique (eg, transatrial vs transven-
tricular approach) for TOF still exists,19 and this has re-
sulted from a lack of long-term follow-up data confirming
the superiority of any 1 approach. Lindberg and col-
leagues,2 in their long-term follow-up study, found no dif-
ferences between transatrial and transventricular repair on
survival or repeat repair.2 Recently, d’Udekem and col-
leagues20 reported a low risk of PVR for RV dilatation
(87% freedom from PVR at 25 years) after a policy of trans-
atrial repair delayed beyond the neonatal period. However, a
lack of objective MRI data in their study was a limitation in
confirming the superiority of their approach, because the in-
dications for PVR have varied among centers. McKenzie
and colleagues21 reported that most patients undergoing
an ‘‘RV infundibulum sparing’’ approach had an RV
EDVI of<170 mL/m2 (mean 132) and preserved RV EF
as assessed by MRI. However, the median interval to MRI
in their study was relatively short (median, 7.9 years).
Because a longer interval since repair is a risk factor for
RV dilatation, longer term follow-up data are necessary to
confirm the beneficial effects of their approach. One should
remember that many technical factors other than the length
of RV incision could also influence late outcomes. These
factors include the width of the transannular patch (TAP),
number of coronary arterial branches sacrificed, extent of
infundibular muscle resection, and so forth. It has recently
been shown that intersurgeon variability in the long-term
outcomes after TOF repair was present, although they fol-
lowed the same surgical policy.22diovascular Surgery c Volume 148, Number 6 2591
TABLE 3. Predictors for right ventricular end-diastolic volume index (n ¼ 160)
Predictor
Univariable analysis Multivariable analysis
b (95% CI) P value b (95% CI) P value
Male sex 18.12 (6.88, 29.36) .002 17.55 (8.18, 26.93) <.001
Palliation 4.00 (22.63, 14.62) .672
Age at repair (y) 0.22 (1.12, 1.55) .750
TAP 0.34 (14.78, 15.46) .965
VSD closure through RV 11.78 (0.35, 23.20) .044
Interval since repair (y) 1.25 (0.00, 2.50) .050 1.29 (0.27, 2.31) .014
RVOTO 0.48 (20.54, 21.50) .964
PAI (mm2/m2) 0.07 (0.01, 0.13) .031
PR fraction (%) 1.94 (1.44, 2.43) <.001 1.92 (1.45, 2.40) <.001
CI, Confidence interval; TAP, transannular patch; VSD, ventricular septal defect; RV, right ventricle; RVOTO, right ventricular outflow tract obstruction; PAI, pulmonary artery
index; PR, pulmonary regurgitation.
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DA longer interval since repair was independently
associated with RV dilatation. This finding was as expected
and in accordance with the study by van den Berg and col-
leagues.23 Because a longer interval since repair is a risk
factor for RV dilatation, timely PVR before the develop-
ment of irreversible RV dilatation and dysfunction is of a
great clinical concern.7 What remains to be elucidated in
the future, preferably by serial MRI examinations, is the
course of RV dilatation and dysfunction. This will be impor-
tant to assist in refining the optimal timing of PVR, which is
still an issue with many controversies.
We found that a greater PR fraction was independently
associated with RV dilatation and dysfunction. The associ-
ation between the PR fraction and RV volumewas expected,
because previous studies have demonstrated a close rela-
tionship between the degree of PR and the RV volume.4,24
In accordance with our finding, other studies have also
found that a greater PR fraction was an independent
predictor for larger RV volumes.15,23,25 However, the
association between a greater PR fraction and lower RV
EF found in our study has not been demonstrated
consistently in previous studies.23-26
In our study, a larger PAI was associated with a larger RV




Male sex 14.50 (4.97, 24.03)
Palliation 1.44 (17.18, 14.30)
Age at repair (y) 0.28 (1.40, 0.85)
TAP 0.06 (12.72, 12.83)
VSD closure through RV 11.68 (2.07, 21.28)
Interval since repair (y) 0.73 (0.34, 1.79)
RVOTO 7.75 (25.47, 9.97)
PAI (mm2/m2) 0.03 (0.02, 0.08)
PR fraction (%) 1.44 (1.00, 1.88)
CI, Confidence interval; TAP, transannular patch; VSD, ventricular septal defect; RV, right
index; PR, pulmonary regurgitation.
2592 The Journal of Thoracic and Cardiovascular Surartery stenosis might be protective against RV dilatation.
Our finding is in accordance with those from previous
studies.16,27 Kogon and colleagues16 found that the small
branch pulmonary artery diameter lengthened the interval
between pulmonary valve disruption and PVR. Maskatia
and colleagues27 found that bilateral and unilateral branch
pulmonary artery stenosis was associated with a lesser PR
fraction and smaller RVEDVI than those in patients without
stenosis, likely owing to the development of restrictive
physiology.7 In contrast, other studies have demonstrated
that experimentally induced unilateral branch pulmonary
artery stenosis resulted in increased PR, in both humans
and a swine model.28,29 These conflicting results
should be interpreted cautiously, because the degree of PR
was determined by pulmonary artery compliance and
resistance (afterload) proximal or distal to the
compliance.10,30,31 PR can be exacerbated by increased
pulmonary artery compliance and elevated resistance
distal to it but can be limited by more proximal resistance.
In our study, the presence of RVOTO at MRI showed a
tendency toward a greater RV EF on univariable analysis,
although it did not reach statistical significance
(P ¼ .058). Previous studies have demonstrated the benefi-
cial effects of residual RVOTO on RV volume and function60)
Multivariable analysis
P value b (95% CI) P value








<.001 1.38 (0.95, 1.80) <.001
ventricle; RVOTO, right ventricular outflow tract obstruction; PAI, pulmonary artery
gery c December 2014
TABLE 5. Predictors of right ventricular ejection fraction (n ¼ 160)
Predictor
Univariable analysis Multivariable analysis
b (95% CI) P value b (95% CI) P value
Male sex 3.17 (5.91, 0.43) .024 3.10 (5.66, 0.53) .018
Palliation 0.63 (5.11, 3.84) .780
Age at repair (y) 0.21 (0.11, 0.53) .192
TAP 0.26 (3.37, 3.89) .887
VSD closure through RV 3.67 (6.38, 0.95) .008 3.05 (5.63, 0.48) .020
Interval since repair (y) 0.07 (0.38, 0.23) .640
RVOTO 4.82 (0.17, 9.80) .058
PAI (mm2/m2) 0.00 (0.02, 0.01) .811
PR fraction (%) 0.29 (0.42, 0.16) <.001 0.27 (0.40, 0.14) <.001
CI, Confidence interval; TAP, transannular patch; VSD, ventricular septal defect; RV, right ventricle; RVOTO, right ventricular outflow tract obstruction; PAI, pulmonary artery
index; PR, pulmonary regurgitation.
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Din patients with repaired TOF.15,25,32 Although we could not
demonstrate the beneficial effects of residual RVOTO on
the RV volume and function, this might have resulted
from the small number of patients with RVOTO (n ¼ 10)





(n ¼ 110) P value
Male sex 61 (56) 59 (54) .673
Palliation 17 (16) 7 (6) .027
Age at repair (y) 4.0  5.3 2.0  2.5 <.001
Type of repair .782
TAP 83 (77) 82 (75)
Non-TAP 16 (15) 20 (18)
No information 9 (8) 8 (7)
Route of VSD closure <.001
RV 60 (56) 38 (35)
RA 22 (20) 51 (46)
No information or other 26 (24) 21 (19)
RVOTO <.001
Yes 8 (7) 10 (9)
No 98 (91) 77 (70)
No information 2 (2) 23 (21)
Interval between repair
and MRI (y)
16.0  4.9 15.5  4.7 .455
RV EDVI (mL/m2) 162  38 132  27 <.001
RV ESVI (mL/m2) 83  33 59  19 <.001
RV EF (%) 50  9 56  7 <.001
PR fraction (%) 46  9 40  10 <.001
PR volume (mL/m2) 36  12 29  11 <.001
LV EDVI (mL/m2) 77  13 74  11 .152
LV ESVI (mL/m2) 31  9 27  6 .003
LV EF (%) 61  7 63  6 .004
PAI (mm2/m2) 169  116 178  66 .488
QRS duration (ms) 147  28 (n ¼ 62) 135  26 (n ¼ 79) .010
PVR, Pulmonary valve replacement; TAP, transannular patch; VSD, ventricular septal
defect; RV, right ventricle/ventricular; RA, right atrium; RVOTO, right ventricular
outflow tract obstruction; MRI, magnetic resonance imaging; EDVI, end-diastolic
volume index;ESVI, end-systolic volume index;EF, ejection fraction;PR, pulmonary
regurgitation; LV, left ventricular; PAI, pulmonary artery index.
The Journal of Thoracic and Carfound that postoperative mild residual pulmonary stenosis
(peak systolic gradient, 15-30 mm Hg) reduced the risk of
PVR during follow-up of patients with corrected TOF. Fri-
giola and colleagues33 found that late survivors of TOF
repair who were free from PVR and had a normal exercise
capacity were characterized by mild residual RVOTO (peak
systolic gradient, 24  13 mm Hg). The mechanism by
which mild residual RVOTO will protect patients against
RV dilatation and dysfunction remains unclear. Possibly,
the smaller regurgitant orifice area and decreased RV
compliance produced by RVOTO might each play a
role.30 Although the findings of previous studies have
stressed the importance of conservative relief of RVOTO
in patients with TOF, the optimal degree of ‘‘beneficial’’
RVOTO remains to be determined. Also, it could be difficult
to target the optimal degree of RVOTO intraoperatively,
because it has previously been shown that a tendency exists
for a marked reduction in the transpulmonary gradient for
6 months postoperatively.34
An interesting finding from our study was that a specific
type of repair (TAP vs non-TAP) was not associated with
RV dilatation and dysfunction. One should know that pres-
ervation of pulmonary valve annulus at TOF repair does not
guarantee a competent pulmonary valve.30 d’Udekem and
colleagues35 found no difference between RV and transan-
nular patching with regard to late clinical outcomes (cardiac
death, PVR, and impaired functional status), RV size, or
incidence of severe PR. The similarity in the outcomes of
patients with TAP repair and those with non-TAP repair
has also been demonstrated by other studies.13,14 We
speculate that these findings resulted because late PR is a
consequence of all repair types and not specific only to
TAP, except for a small proportion of the patients with the
most favorable pulmonary valve morphology.
Study Limitations
The present study was limited by its retrospective nature.
The present study population did not represent the entire
spectrum of patients who underwent TOF repair, becausediovascular Surgery c Volume 148, Number 6 2593
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Donly those patients who had undergone MRI examination
were included. It is possible that a selection bias was present
that resulted in important differences between the patients
who did and did not undergo MRI, although we could not
be sure because we did not have the data to describe the dif-
ferences between the 2 groups. The patients with any
missing data for the potential predictors of RV volumes
and function were excluded from the analyses, which might
have biased our results. Many surgeons were involved in the
repair of our study patients. Therefore, the repair tech-
niques, such as the length of the RV incision, width of the
TAP, extent of infundibular muscle resection, and removal
of the pulmonary valve leaflets, were not constant. Such
technical details could all have influenced the long-term
outcomes of our patients.
CONCLUSIONS
Male sex, VSD closure through the right ventricle, a
longer interval since repair, and greater PR fraction were in-
dependent predictors of RV dilatation after TOF repair.
Male sex, VSD closure through the right ventricle, and
greater PR fraction were also independent predictors of
RV dysfunction. Additional studies are necessary to clarify
whether residual RVOTO after TOF repair can protect
against the deleterious consequences of chronic PR. Under-
standing the predictors of RV dilatation and dysfunction in
patients with repaired TOF is important to refine the clinical
counseling, to improve follow-up protocols, and, ultimately,
to clarify the optimal surgical management of TOF for bet-
ter long-term outcomes.
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Dr Charles D. Fraser (Houston, Tex). I really congratulate Dr
Lee and colleagues for this important addition to our body of
knowledge concerning the long-term effects of TOF repair on
RV performance. This study really was beautifully presented,
and I congratulate you on the concise nature of your slides and
how clear and instructive they are.
From your original cohort of 251 patients undergoing TOF
repair, some by classic RV outflow tract incisions, some by the
transatrial/transpulmonary approach, 171 had complete MRI eval-
uations of RV performance at a mean of 15.5 years after the index
correction. In your multivariable analysis for factors associated
with late RV dilatation and dysfunction, you found male sex, inter-
val from the original operation, and pulmonary regurgitant fraction
to be independent predictors of an increased RVend-diastolic vol-
ume index. Of interest, residual RVOTO appears to be protective
against RV dilatation and dysfunction.
My questions, first, the goal of the study was to provide addi-
tional insight into the treatment of these patients. Based on that
premise, how has your thinking now evolved in terms of modifica-
tions you will make to the primary operation that you believe will
confer long-term protection to RV function?
Dr Lee. Thank you for your excellent comments and question,
Dr Fraser.
My institution is performing elective transatrial repair at 3 to 6
months of age for asymptomatic patients, and we prefer primary
repair for the younger symptomatic infants. From ours, and other
studies, I believe that leaving some degree of RVOTO will be pro-
tective against RV dilatation and dysfunction in the long term.
However, the optimal degree of RVOTO remains to be determined,
and our study could not answer this question. Moreover, it could be
difficult to target the optimal degree of RVOTO intraoperatively,
because we know that a tendency exists for a significant reduction
in the transpulmonary gradient postoperatively. Additional studies
are necessary to clarify this issue.
Dr Fraser. So, just to expand on that just a little bit, and I know
there will be some other questions, but you would tend to leave a
little more obstruction, be a little less liberal with your resection,
and, where possible, would you preserve the moderator band?The Journal of Thoracic and CarDr Lee. Yes, I think it is important to perform less resection of
the infundibulum, to leave some degree of RVOTO. In our study,
we found that the route of VSD closure was not an independent
factor for RV dilatation and dysfunction. Last year, at this meeting,
we presented rather disappointing results about limited RV inci-
sion in patients who underwent transannular repair. However, the
findings of our study should not be interpreted as discouraging
the use of the transatrial/transpulmonary approach for TOF repair.
We still believe that transatrial/transpulmonary repair of TOF has
some role for better long-term outcomes.
Dr Fraser. Just 2 quick more questions then. Tell us your insti-
tutional protocol for choosing patients for PVR now. What
threshold do you use in terms of the interval from surgery, regur-
gitant fraction, end-diastolic volume, and so on?
Dr Lee. My institution is rather aggressive toward PVR. Defi-
nitely, we recommend PVR for patients with symptoms or exercise
intolerance. For the asymptomatic patients—can I go back—this is
our recent report about PVR in our center. In this study, the median
age at PVR was about 17 years, and we found that PVR should be
considered before the RV EDVI exceeded 163 mL/m2 or the RV
end-systolic volume index exceeded 80 mL/m2 to achieve postop-
erative normalization of the RV volumes and function. It is diffi-
cult to know whether achieving normal RV volumes and
function after PVR is absolutely necessary for better long-term
outcomes; however, until proved otherwise, we have trying to
not exceed these cutoff values for the asymptomatic patients.
However, in practice, it has not always been possible to do this.
Sometimes, our cardiologists perform echocardiography and find a
severely dilated right ventricle, then they perform theMRI and find
a severely, very severely dilated right ventricle, for example, an RV
EDVI of 200 mL/m2. For this patient, I think we would be oper-
ating too late.
Therefore, to incorporate these cutoff values into the clinical de-
cision-making process, we should know the course of RV dilata-
tion and dysfunction. Also, I think this can be done by
performing serial MRI examinations, and this is an important issue
for future studies to assist in refining the optimal timing of PVR.
Dr Fraser. One last question. I cannot resist. So, as those of us
who have been married as long as I have know, the male sex is
disadvantaged. Why is that so in patients with TOF?
Dr Lee. Our result about the male sex is in accordance with the
findings from some previous studies. For example, the Atlanta
group reported that male sex was a significant risk factor for a
shorter interval between pulmonary valve disruption and PVR.
However, it is difficult to ascertain whether true sex-specific differ-
ences exist in the RV response to chronic volume overload,
because previous studies have reported sex-specific differences
in normal RV volumes and function. If our study result is simply
a reflection of the sex-specific differences in normal RV volumes,
I think we should apply sex-specific criteria for prescribing PVR.
Female patients will experience relatively more severe RV dilata-
tion and dysfunction if we use unisex criteria for PVR, and,
certainly, this will be an area of future study.
DrHillel Laks (Los Angeles, Calif).Aquestion and a comment.
First of all, the sex difference could be related to the degree of
physical activity in the first 12 years of life, or 14 or 15 or 18 years
of life, and males might be much more active during this period
than females, but that is just speculation.diovascular Surgery c Volume 148, Number 6 2595
Congenital Heart Disease Lee et al
C
H
DThe second point is, I think, it is very important when we talk
about MRIs of the right ventricle to differentiate between 2 por-
tions of the right ventricle. The right ventricle has a contractile
ejecting lower chamber and an outflow tract. It is not infrequent,
and we have seen this in our own institution, where a patient can
have a patch that was made transannular with a huge RVaneurysm
and pulmonary artery aneurysm. However, the actual contracting
chamber below it will not be dilated and will beworking extremely
well. The MRI personnel who perform these studies include the
infundibulum and this aneurysm as part of their volume and in
calculating the EF. So, depending on the technique used, you
can have an outsized volume and a lower EF in a patient whose
actual contractile chamber is still doing extremely well. We try
to differentiate that. If it is just the aneurysm issue, because a non-
treated pericardial patch was used and was made too large, that
does not mean the right ventricle is failing. I assume that in your
institution, with close to 80% TAPs, that the surgeons were
extremely careful not to make very large incisions down into the
right ventricle and not to use a patch that would expand and cause
that to explain your excellent results and the lack of differentiation.
So, I think that until the time comes when we start asking our
radiologists and cardiologists who do these calculations to sepa-
rate these 2 issues, we will not have a good idea on what is actually
happening to RV function, in contrast to global issues that are
frequently surgeon-related and technique-related.
Dr Lee. Thank you for your comments. I agree with your
opinion about the functioning RV trabecular portion and that2596 The Journal of Thoracic and Cardiovascular Surmeasuring the RV trabecular portion’s volume and function is
important. However, I heard from my radiologist that it was not al-
ways clear to divide the right ventricle into the trabecular and
infundibular portion. That is a problem.
Dr Christoper A. Caldarone (Toronto, Ontario, Canada).
Could I just ask, in your multivariable analysis, the RV EF ap-
peared to be associated with some improvement in the face of
RVOTO and the hazard ratio was 5.4. What are the units in that
hazard ratio? For example, is it expressed in some percentage of
change in the EF normalized by some change in the pressure
gradient?
Dr Lee. RVOTO was entered into the analysis as yes or no, the
presence or absence of RVOTO.
Dr Caldarone. Oh, I see. So, this is a binary association?
Dr Lee. Yes.
Dr Caldarone. So that would be an interesting relationship to
study. Rather than creating discrete intervals in the RV outflow
tract gradient, the use of this variable as a continuous variable
would be informative.
The other point to consider is an interaction term might be pre-
sent between RVOTO and the regurgitant fraction. A greater regur-
gitant fraction could be associated with a greater gradient.
However, perhaps a gradient is protective, exactly as you said.
But, I think those 2 terms really need to be examined carefully
for a potential interaction in confounding your analysis.
Dr Lee.We did not examine the relationship between RVOTO
and regurgitant fraction, so I cannot answer that question.gery c December 2014
